Explore 3 Stock Ideas & Industry Insights Download Free Report

Ocumetics Technology Corp

Company price
0.4 CAD 0.00(0%)
Last update at 2026-11-04T20:22:00Z
VOLUME
16500
Market Cap
78.80M

Momentum Score

…

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.40
High
52 Week Price Range
0.26
Low
1.58
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ocumetics Technology Corp appears to develop intraocular lens technology aimed at improving vision outcomes for patients undergoing cataract or refractive lens procedures. Long-term growth may be supported by aging demographics and rising procedural volumes, and the company's novel lens approach could make it appealing to investors seeking exposure to ophthalmic device innovation.

The primary risks include early-stage development with limited clinical evidence, regulatory approval uncertainty, sparse public disclosure and low trading liquidity that may impede fundraising and commercialization.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.40
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-1122.68%
Net Debt
3.76M
ROCE
-120.26%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Income before tax -3.06M -3.64M -2.22M -2.22M -0.60M
Net income -3.02M -3.64M -2.22M -2.22M -0.60M
Selling general administrative 1.26M 2.54M 1.45M 1.45M 0.51M
Reconciled depreciation 0.13M 0.12M 0.10M 0.10M 0.08M
Ebit - - - - -0.65M
Ebitda - - -2.09M -2.09M -0.51M
Operating income -2.43M -3.61M -2.18M -2.10M -0.60M
Interest expense 0.64M 0.03M 0.03M 0.03M 0.00M
Tax provision -0.04M - - - -
Interest income 0.04M - - - -
Net interest income -0.60M -0.03M -0.03M -0.03M -
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 2.43M 3.61M 2.18M 2.10M 0.60M
Total other income expense net -0.04M -0.01M -0.01M -0.09M -0.05M
Net income from continuing ops -3.02M -3.64M -2.22M -2.22M -0.60M
Net income applicable to common shares - - - - -0.65M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Total assets 2.32M 1.04M 1.37M 1.37M 0.83M
Intangible assets 0.62M 0.66M 0.70M 0.70M 0.62M
Total liab 4.26M 0.95M 0.54M 0.54M 1.10M
Total stockholder equity -1.94M 0.09M 0.84M 0.84M -0.27M
Other current liab - - - - 0.37M
Common stock - - - - 1.51M
Capital stock 7.80M 7.45M 5.36M 5.36M 1.51M
Retained earnings -12.20M -9.18M -5.53M -5.53M -1.83M
Other liab - - - - 0.50M
Other assets - - - - 0.09M
Cash 0.20M 0.24M 0.60M 0.60M 0.08M
Total current liabilities 0.31M 0.62M 0.24M 0.24M 0.64M
Net debt 3.76M 0.09M - - -
Other stockholder equity - - - - 0.27M
Total current assets 1.65M 0.31M 0.67M 0.67M 0.11M
Net tangible assets - - - - -0.94M
Short term investments 1.38M - - - -
Net receivables - 0.00M 0.00M 0.00M 0.03M
Long term debt 3.95M 0.32M 0.29M - -
Accounts payable 0.23M 0.55M 0.17M 0.17M 0.06M
Non currrent assets other - - - - 0.09M
Non current assets total 0.68M 0.73M 0.70M 0.70M 0.71M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2022-07-31 2021-12-31
Investments -1.38M -0.14M -0.07M -0.07M -0.21M
Change to liabilities - - - - 0.24M
Total cashflows from investing activities - - - - -0.21M
Net borrowings 3.60M - - - -
Total cash from financing activities 3.85M 1.82M 0.44M 0.44M 0.39M
Change to operating activities - - - - 0.26M
Net income -3.02M -3.64M -2.22M -2.22M -0.60M
Change in cash -0.04M -0.37M -1.24M -1.24M 0.08M
Begin period cash flow 0.24M 0.60M 1.84M 1.84M 0.00M
End period cash flow 0.20M 0.24M 0.60M 0.60M 0.08M
Total cash from operating activities -2.43M -2.05M -1.62M -1.62M -0.09M
Issuance of capital stock 0.26M 1.79M 0.04M 0.04M 0.39M
Depreciation 0.13M 0.12M 0.10M 0.10M 0.08M
Other cashflows from investing activities - - - - -0.09M
Change to account receivables 0.00M 0.00M -0.00M -0.00M -0.03M
Other cashflows from financing activities - - - - -0.09M
Change to netincome - - - - 2.01M
Capital expenditures 0.08M 0.14M 0.07M 0.07M 0.12M
Change in working capital -0.32M 0.38M -0.01M -0.01M 0.43M
Stock based compensation 0.17M 0.49M 0.49M 0.49M 0.00M
Other non cash items 0.64M 0.61M 0.03M 0.03M -
Free cash flow -2.51M -2.19M -1.69M -1.69M -0.21M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
OTC
Ocumetics Technology Corp
-
-%
0.40 - - - 41.07 -79.74
ZEN
ZEN Graphene Solutions Ltd
0.01
1.89%
0.54 - - 79.84 5.93 -14.24
COV
Covalon Technologies Ltd.
0.03
0.70%
4.29 65.00 23.81 1.71 2.04 26.39

Profile*

Ocumetics Technology Corp

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada.

1250, 639-5th Avenue SW, Calgary, AB, Canada, T2P 0M9

403-650-7718

Name Title Year Born
Dr. Garth T. Webb Founder, Chairman & Chief Scientific Officer NA
Dr. Mark Lee Pres & CEO NA
Mr. Roger M. Jewett C.A., CPA CFO & Director NA
Dr. Doyle Stulting Chief Medical Officer NA
Mr. Dean E. Burns President, CEO & Director NA
Mr. Roger M. Jewett C.A., CPA CFO & Director 1964
Dr. R. Doyle Stulting Chief Medical Officer & Director NA
Mr. Roger M. Jewett C.A., CPA CFO & Director 1965
Dr. R. Doyle Stulting Chief Medical Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…